Life Sciences and Healthcare

Top Seven Predictions for PBM industry in 2019

While 2018 was a busy year for pharmacy benefit managers making waves, 2019 looks no different. Vertical integration will undoubtedly remain the key driver for transformation as both the mega-mergers of CVS/Aetna and Cigna/Express Scripts are now completed. These combined healthcare powerhouses are poised to bring some major changes in the outlook of pharmacy benefit […]

Challenges in SLE Drug Development: The Key Hurdles

Systemic Lupus Erythematosus (SLE) is an autoimmune condition characterized by the production of pathogenic autoantibodies and tissue deposition of immune complexes. The disease is extremely heterogeneous in nature—which often leads to delays in diagnosis—although it most commonly affects the musculoskeletal and mucocutaneous systems. The disruption of normal functioning of other organs, such as the kidneys, […]

Licensing deals driving the life sciences industry in Q3: notes and trends

During the third quarter of 2018, Cortellis Competitive Intelligence registered 984 new deals (excluding mergers & acquisitions) with a total disclosed deal value of $26 billion as part of its ongoing coverage of licensing activity in the life sciences sector compared to 1,060 and $20.8 billion in the second quarter and 1,158 and $33.6 billion […]

Q3 M&A deals driving the life sciences industry

Trends in M&A volume and deal value During the third quarter of 2018, Cortellis Deals Intelligence registered 131 new mergers and acquisitions (M&A) with a total disclosed deal value of $16 billion as part of its ongoing coverage of M&A activity in the life sciences sector compared to 113 and $104.6 billion in the second […]

Orphan drug access varies across multiple markets

European countries differ in their value assessment of new orphan drugs, but steps can be taken to create a more harmonized, comparable and rational evidence-based decision-making system in Europe, two experts from the London School of Economics Health reported at the Ninth Orphan Drug Congress 2018. The presentation by Aris Angelis and Panos Kanavos covered […]

Device industry looks to cut time to market

German medical device companies are growing concerned that the approval process in Europe for bringing innovative products to market is taking too long, especially when compared with the U.S., according to a survey conducted by the German medical technology association. In Australia, meanwhile, the Therapeutic Goods Administration (TGA) reported shorter approval timelines for new devices […]

6 strategies to improve your appeal processes

HBI’s research in recent years has indicated a wide range of appeal outcomes among healthcare providers. For example, respondents to one survey noted first-pass success rates anywhere from 6% to 85%, with about half reporting between 40% and 65%. Such variation may be at least partially explained by the wide range of contributing factors, such […]

Big data: The future in healthcare is sooner than we think

Data is, of course, driving the future of healthcare. Stakeholders across the industry have been widely preparing for the Big Data transformation and how to put the data to best use. At the recent Financial Times Global Pharmaceutical and Biotechnology Conference titled “Embracing Disruption for a New Era in Health,” several experts examined how to […]

New medical device regulations: The view from Europe

The increased globalization of the medical device landscape was a recurring theme as the industry gathered in Philadelphia for the MedTech Conference this fall. Sessions looked at recent regulatory and business developments in several key markets including Brazil, China, India and the U.S. Here is a look at one important panel discussion that took place […]

Key considerations when choosing and installing an infant security system

Define Your Requirements Before shopping for systems, hospitals should review their existing infrastructure— including security systems, human resources, hardware and software support, technology devices, storage facilities, and IT services—to support a smooth integration of infant protection solution. Hospitals can form an interdisciplinary team of clinicians, safety representatives, nursing leadership, and educators to outline the facility’s […]